Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M B Youdim

Showing results (321-330 of 349) with videos related to

Pageof 35
Sort By:
European Journal of Pharmacology|August 24, 1993
L-deprenyl confers specific protection against MPTP-induced Parkinson's disease-like movement disorder in the goldfishO M Adeyemo, M B Youdim, S P Markey, et al.
Journal of Neural Transmission. Supplementum|April 24, 2007
Metal specificity of an iron-responsive element in Alzheimer's APP mRNA 5'untranslated region, tolerance of SH-SY5Y and H4 neural cells to desferrioxamine, clioquinol, VK-28, and a piperazine chelatorS Bandyopadhyay, X Huang, H Cho, et al.
Psychological Medicine|May 1, 1979
Tranylcypromine ('Parnate') overdose: measurement of tranylcypromine concentrations and MAO inhibitory activity and identification of amphetamines in plasmaM B Youdim, J K Aronson, K Blau, et al.
Metabolism: Clinical and Experimental|January 1, 1992
The distal axis of growth hormone (GH) in nutritional disorders: GH-binding protein, insulin-like growth factor-I (IGF-I), and IGF-I receptors in obesity and anorexia nervosaZ Hochberg, P Hertz, V Colin, et al.
Journal of Neurochemistry|October 26, 2001
Brain iron pathways and their relevance to Parkinson's diseaseD Berg, M Gerlach, M B Youdim, et al.
Journal of Neurochemistry|May 1, 1993
Neuromelanin and nigrostriatal dopamine neuron degenerationK Jellinger, E Kienzl, G Rumpelmair, et al.
Clinical Endocrinology|August 1, 1991
Effects of hypo or hyper-thyroidism on growth hormone-binding proteinT Amit, P Hertz, S Ish-Shalom, et al.
Journal of Neurochemistry|September 1, 1992
Iron-melanin complex in substantia nigra of parkinsonian brains: an x-ray microanalysisK Jellinger, E Kienzl, G Rumpelmair, et al.
Journal of Neural Transmission|January 1, 1988
Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brainE Sofic, P Riederer, H Heinsen, et al.
Journal of Neural Transmission. Supplementum|February 24, 2001
TV3326, a novel neuroprotective drug with cholinesterase and monoamine oxidase inhibitory activities for the treatment of Alzheimer's diseaseM Weinstock, C Bejar, R H Wang, et al.
Pageof 35

Showing results (321-330 of 349) with videos related to

Sort By:
Pageof 35
European Journal of Pharmacology|August 24, 1993
L-deprenyl confers specific protection against MPTP-induced Parkinson's disease-like movement disorder in the goldfishO M Adeyemo, M B Youdim, S P Markey, et al.
Journal of Neural Transmission. Supplementum|April 24, 2007
Metal specificity of an iron-responsive element in Alzheimer's APP mRNA 5'untranslated region, tolerance of SH-SY5Y and H4 neural cells to desferrioxamine, clioquinol, VK-28, and a piperazine chelatorS Bandyopadhyay, X Huang, H Cho, et al.
Psychological Medicine|May 1, 1979
Tranylcypromine ('Parnate') overdose: measurement of tranylcypromine concentrations and MAO inhibitory activity and identification of amphetamines in plasmaM B Youdim, J K Aronson, K Blau, et al.
Metabolism: Clinical and Experimental|January 1, 1992
The distal axis of growth hormone (GH) in nutritional disorders: GH-binding protein, insulin-like growth factor-I (IGF-I), and IGF-I receptors in obesity and anorexia nervosaZ Hochberg, P Hertz, V Colin, et al.
Journal of Neurochemistry|October 26, 2001
Brain iron pathways and their relevance to Parkinson's diseaseD Berg, M Gerlach, M B Youdim, et al.
Journal of Neurochemistry|May 1, 1993
Neuromelanin and nigrostriatal dopamine neuron degenerationK Jellinger, E Kienzl, G Rumpelmair, et al.
Clinical Endocrinology|August 1, 1991
Effects of hypo or hyper-thyroidism on growth hormone-binding proteinT Amit, P Hertz, S Ish-Shalom, et al.
Journal of Neurochemistry|September 1, 1992
Iron-melanin complex in substantia nigra of parkinsonian brains: an x-ray microanalysisK Jellinger, E Kienzl, G Rumpelmair, et al.
Journal of Neural Transmission|January 1, 1988
Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brainE Sofic, P Riederer, H Heinsen, et al.
Journal of Neural Transmission. Supplementum|February 24, 2001
TV3326, a novel neuroprotective drug with cholinesterase and monoamine oxidase inhibitory activities for the treatment of Alzheimer's diseaseM Weinstock, C Bejar, R H Wang, et al.
Pageof 35